A randomised, double-blind, placebo-controlled study to evaluate the efficacy of imiquimod 5% in women with vulvar intraepithelial neoplasia 2 and 3
Phase of Trial: Phase II
Latest Information Update: 14 Jan 2011
At a glance
- Drugs Imiquimod (Primary)
- Indications Human papillomavirus infections; Vulvar intraepithelial neoplasia; Vulvovaginal cancer
- Focus Therapeutic Use
- 03 Apr 2008 Results have been published.
- 02 Oct 2006 New trial record.